ACADIA PHARMACEUTICALS INC — Director's Dealing 2012

Mar 26, 2012

SEC Form 4/A — Form 4/A

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2012-03-23

Reporting Person: Baity Glenn (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-23	Stock Option (right to buy)	$2.18	A	130000	Acquired	2022-03-22	Common Stock (130000)	Direct

Footnotes

F1: Price was incorrectly listed as $1.18 in original filing.

F2: 25% of the shares subject to the Stock Option vest and become exercisable on March 23, 2013. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.